Panbela provides business update and reports q4 and fy 2020 financial results

Minneapolis, march 25, 2021 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today provides a business update and reports financial results for the quarter and full year ended december 31, 2020. management is hosting an earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking